1. Home
  2. WYY vs HYFT Comparison

WYY vs HYFT Comparison

Compare WYY & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WidePoint Corporation

WYY

WidePoint Corporation

HOLD

Current Price

$5.04

Market Cap

48.1M

Sector

Technology

ML Signal

HOLD

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.28

Market Cap

55.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WYY
HYFT
Founded
1991
1983
Country
United States
United States
Employees
N/A
102
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
55.1M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
WYY
HYFT
Price
$5.04
$1.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.67
$5.00
AVG Volume (30 Days)
30.0K
202.9K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$150,545,364.00
N/A
Revenue This Year
$14.41
N/A
Revenue Next Year
$11.41
$29.18
P/E Ratio
N/A
N/A
Revenue Growth
5.59
N/A
52 Week Low
$2.80
$0.99
52 Week High
$7.55
$3.00

Technical Indicators

Market Signals
Indicator
WYY
HYFT
Relative Strength Index (RSI) 50.25 55.32
Support Level $4.95 $1.02
Resistance Level $5.85 $1.31
Average True Range (ATR) 0.29 0.11
MACD 0.03 0.03
Stochastic Oscillator 59.99 58.51

Price Performance

Historical Comparison
WYY
HYFT

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: